Elevance Health Inc. (NYSE:ELV) shares fell after the health insurer reported mixed fourth-quarter 2025 earnings and bleak fiscal 2026 guidance. The stock has recovered most of its loss from the premarket sessionEarnings SnapshotThe company reported fourth-quarter 2025 revenues of $49.3 billion, up 10$49.82 billion. Operating revenue was $197.6 billion in 2025, up 13%.The increase in revenue for the quarter and year was driven by higherpremium yields in the Health Be ...